![Steven Glauser](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 300 701 $ per 2026-07-31
Mr. Steven J.
Glauser is an Independent Non-Executive Director at ZEO ScientifiX, Inc. He is on the Board of Directors at ZEO ScientifiX, Inc. and National Jewish Health, Inc. Mr. Glauser was previously employed as a Principal by Sorrento Therapeutics, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ZEO SCIENTIFIX INC. 3,3 % | 2026-01-28 | 258 334 ( 3,3 % ) | 300 701 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| ORGANICELL REGENERATIVE MEDICINE INC | Direktör/Styrelseledamot | 2022-09-23 |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
ZEO ScientifiX, Inc.
 ZEO ScientifiX, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops biological therapeutics for the treatment of degenerative diseases | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
National Jewish Health, Inc.
National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
